Registered entities
Ensoma, Inc.
Reg. No. 84-2970518United States
Innovation
15 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 475 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 3 |
Social engagement
Social engagement: 11.1K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
20 investors on record; lead investors include 5AM Ventures, Arix Bioscience.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 40% |
| Private equity | 3 | 15% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 8 | 40% |
Recent activity
24 Jun 2026
Event
BIO2026
15 Jun 2026
Event
BIO International Convention on In Vivo Hematopoietic Stem Cell Engineering for One-Time Genetic Medicines
8 May 2026
Event
American Society of Gene & Cell Therapy annual meeting